Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jose Tanus-Santos
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Physiology
Living Beings
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
37
Gerlach, Raquel
20
Moreno, Heitor
20
Sandrim, Valeria
13
Dias-Junior, Carlos
12
Barbosa, Fernando
10
Metzger, Ingrid
10
Montenegro, Marcelo
9
Souza-Costa, Debora
8
Flockhart, David
7
Cittadino, Máira
7
Uzuelli, Juliana
6
Demacq, Caroline
6
Bendhack, Lusiane
6
Nagassaki, Sabrina
5
Sabha, Maricene
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jose Tanus-Santos (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Marcaccini Andrea M; Novaes Arthur B; Meschiari Cesar A; Souza Sergio L; Palioto Daniela B; Sorgi Carlos A; Faccioli Lucia H; Tanus-Santos Jose E; Gerlach Raquel F
Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
Clinica chimica acta; international journal of clinical chemistry 2009;409(1-2):117-22.
-
2009: Uzuelli Juliana A; Dias-Junior Carlos A C; Izidoro-Toledo Tatiane C; Gerlach Raquel F; Tanus-Santos Jose E
Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism.
Clinica chimica acta; international journal of clinical chemistry 2009;409(1-2):112-6.
-
2009: Muniz Jaqueline J; Izidoro-Toledo Tatiane C; Metzger Ingrid F; Sandrim Valeria C; Tanus-Santos Jose E
Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms.
DNA and cell biology 2009;28(11):567-72.
-
2009: Martins-Oliveira Alisson; Speciali Jose G; Dach Fabiola; Marcaccini Andrea M; Gonçalves Flavia M; Gerlach Raquel F; Tanus-Santos J E
Different circulating metalloproteinases profiles in women with migraine with and without aura.
Clinica chimica acta; international journal of clinical chemistry 2009;408(1-2):60-4.
-
2009: Demacq C; Vasconcellos V B; Marcaccini A M; Gerlach R F; Machado A A; Tanus-Santos J E
A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.
The pharmacogenomics journal 2009;9(4):265-73.
-
2009: Luizon Marcelo R; Izidoro-Toledo Tatiane C; Simoes Aguinaldo L; Tanus-Santos Jose E
Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians.
DNA and cell biology 2009;28(7):329-34.
-
2009: Belo Vanessa A; Souza-Costa Debora C; Lana Carla M; Caputo Fabio L D; Marcaccini Andrea M; Gerlach Raquel F; Bastos Marcus G; Tanus-Santos Jose E
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Clinical biochemistry 2009;42(10-11):984-90.
-
2009: Dias-Junior Carlos A; Cau Stefany B A; Oliveira Alisson M; Castro Michele M; Montenegro Marcelo F; Gerlach Raquel F; Tanus-Santos Jose E
Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress.
Thrombosis research 2009;124(3):349-55.
-
2009: Montenegro Marcelo F; Pessa Lisandra R; Gomes Valéria A; Desta Zeruesenay; Flockhart David A; Tanus-Santos Jose E
Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed.
Basic & clinical pharmacology & toxicology 2009;104(5):400-7.
-
2009: Gonçalves Flavia M; Jacob-Ferreira Anna L B; Gomes Valeria A; Casella-Filho Antonio; Chagas Antonio C P; Marcaccini Andrea M; Gerlach Raquel F; Tanus-Santos Jose E
Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Clinica chimica acta; international journal of clinical chemistry 2009;403(1-2):173-7.
-
2009: Castro Michele M; Rizzi Elen; Rodrigues Gerson J; Ceron Carla S; Bendhack Lusiane M; Gerlach Raquel F; Tanus-Santos Jose E
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
Free radical biology & medicine 2009;46(9):1298-307.
-
2009: Rizzi Elen; Castro Michele M; Fernandes Karla; Barbosa Fernando; Arisi Gabriel Maisonnave; Garcia-Cairasco Norberto; Bendhack Lusiane M; Tanus-Santos Jose E; Gerlach Raquel F
Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension.
Archives of toxicology 2009;83(5):439-49.
-
2009: Montenegro Marcelo F; Pessa Lisandra R; Tanus-Santos Jose E
Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin.
European journal of pharmacology 2009;607(1-3):173-7.
-
2009: Nagassaki S; Herculano R D; Graeff C F O; Tanus-Santos J E
eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity.
European journal of clinical pharmacology 2009;65(4):385-92.
-
2009: Sandrim Valeria C; Palei Ana C T; Cavalli Ricardo C; Araújo Francielle M; Ramos Ester S; Duarte Geraldo; Tanus-Santos Jose E
Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension.
Molecular human reproduction 2009;15(2):115-20.
-
2009: de Vasconcelos Daniel; Izidoro-Toledo Tatiane C; Sandrim Valeria C; Tanus-Santos Jose E; Palei Ana C T; Cavalli Ricardo C
Aldosterone synthase gene polymorphism is not associated with gestational hypertension or preeclampsia.
Clinica chimica acta; international journal of clinical chemistry 2009;400(1-2):139-41.
-
2009: Gerlach Raquel F; Meschiari Cesar A; Marcaccini Andrea M; Palei Ana C T; Sandrim Valeria C; Cavalli Ricardo C; Tanus-Santos Jose E
Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(7):888-91.
-
2008: Martinez Marcio L L; Rizzi Elen; Castro Michele M; Fernandes Karla; Bendhack Lusiane M; Gerlach Raquel F; Tanus-Santos Jose E
Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
European journal of pharmacology 2008;599(1-3):110-6.
-
2008: Gomes Valéria A; Casella-Filho Antonio; Chagas Antonio C P; Tanus-Santos Jose E
Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2008;19(4):345-50.
-
2008: Sandrim Valeria C; Palei Ana Ct; Cavalli Ricardo C; Araújo Francielle M; Ramos Ester S; Duarte Geraldo; Tanus-Santos Jose E
eNOS haplotypes associated with gestational hypertension or preeclampsia.
Pharmacogenomics 2008;9(10):1467-73.
-
2008: Dias-Junior Carlos A; Montenegro Marcelo F; Florencio Barbara C; Tanus-Santos Jose E
Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism.
Basic & clinical pharmacology & toxicology 2008;103(4):374-9.
-
2008: Martinez Marcio L L; Castro Michele M; Rizzi Elen; Fernandes Karla; Demacq Caroline; Bendhack Lusiane M; Gerlach Raquel F; Tanus-Santos Jose E
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
European journal of pharmacology 2008;591(1-3):224-30.
-
2008: Sandrim Valeria C; Palei Ana C T; Metzger Ingrid F; Gomes Valeria A; Cavalli Ricardo C; Tanus-Santos Jose E
Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia.
Hypertension 2008;52(2):402-7.
-
2008: Demacq Caroline; Metzger Ingrid F; Gerlach Raquel F; Tanus-Santos Jose E
Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers.
Clinica chimica acta; international journal of clinical chemistry 2008;394(1-2):72-6.
-
2008: Palei Ana C T; Sandrim Valeria C; Cavalli Ricardo C; Tanus-Santos Jose E
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Clinical biochemistry 2008;41(10-11):875-80.
-
2008: Dias-Junior Carlos Alan; Cau Stefany Bruno de Assis; Tanus-Santos José Eduardo
[Role of nitric oxide in the control of the pulmonary circulation: physiological, pathophysiological, and therapeutic implications]
Jornal brasileiro de pneumologia : publicaça?o oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2008;34(6):412-9.
-
2008: Castro Michele M; Rizzi Elen; Figueiredo-Lopes Lívia; Fernandes Karla; Bendhack Lusiane M; Pitol Dimitrius Leonardo; Gerlach Raquel F; Tanus-Santos Jose E
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
Atherosclerosis 2008;198(2):320-31.
-
2008: Montenegro Marcelo Freitas; Barbosa Fernando; Tanus-Santos Jose E
Assessment of how pregnancy modifies plasma lead and plasma/whole blood lead ratio in ALAD 1-1 genotype women.
Basic & clinical pharmacology & toxicology 2008;102(4):347-51.
-
2008: Mannello Ferdinando; Tanus-Santos Jose E; Meschiari Cesar A; Tonti Gaetana A
Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices.
Analytical biochemistry 2008;374(1):56-63.
-
2008: Cau Stefany B A; Dias-Junior Carlos A; Montenegro Marcelo F; de Nucci Gilberto; Antunes Edson; Tanus-Santos Jose E
Dose-dependent beneficial hemodynamic effects of BAY 41-2272 in a canine model of acute pulmonary thromboembolism.
European journal of pharmacology 2008;581(1-2):132-7.
-
2008: Uzuelli Juliana A; Dias-Junior Carlos A C; Tanus-Santos Jose E
Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism.
Clinica chimica acta; international journal of clinical chemistry 2008;388(1-2):184-8.
-
2008: Rezende Vania B; Barbosa Fernando; Montenegro Marcelo F; Sandrim Valeria C; Gerlach Raquel F; Tanus-Santos Jose E
Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects.
Archives of toxicology 2008;82(1):29-36.
-
2008: Demacq Caroline; Vasconcellos Vivian B; Marcaccini Andrea M; Gerlach Raquel F; Silva Wilson A; Tanus-Santos Jose E
Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(1):57-63.
-
2007: Mannello Ferdinando; Tonti Gaetana A; Tanus-Santos Jose E; Gerlach Raquel F
Silicate increases the release of MMP-9 forms in peripheral blood: why gelatin zymography differs significantly in citrate plasma and serum obtained with or without clot activators.
Clinical chemistry 2007;53(11):1981-2.
-
2007: Dias-Junior C A C; Sertorio J T C; Tanus-Santos J E
Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism.
Acta physiologica (Oxford, England) 2007;191(3):189-96.
-
2007: Metzger Ingrid F; Sertório Jonas T C; Tanus-Santos Jose E
Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes.
Free radical biology & medicine 2007;43(6):987-92.
-
2007: Rezende Vania B; Barbosa Fernando; Montenegro Marcelo F; Sandrim Valeria C; Gerlach Raquel F; Tanus-Santos Jose E
An interethnic comparison of the distribution of vitamin D receptor genotypes and haplotypes.
Clinica chimica acta; international journal of clinical chemistry 2007;384(1-2):155-9.
-
2007: Souza-Costa Débora C; Sandrim Valéria C; Lopes Lívia F; Gerlach Raquel F; Rego Eduardo M; Tanus-Santos Jose E
Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene.
Atherosclerosis 2007;193(2):438-44.
-
2007: Sandrim Valeria C; de Syllos Roger W C; Lisboa Hugo R K; Tres Glaucia S; Tanus-Santos Jose E
Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2007;16(3):348-55.
-
2007: Tanus-Santos Jose Eduardo; Casella-Filho Antonio
Cardiovascular mortality in high-risk patients and T-786C polymorphism in promoter region of the endothelial nitric oxide synthase gene.
Journal of the American College of Cardiology 2007;49(11):1225-6; author reply 1226-7.
-
2007: Gerlach Raquel F; Demacq Caroline; Jung Klaus; Tanus-Santos Jose E
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma.
Clinical biochemistry 2007;40(1-2):119-23.
-
2007: Souza-Costa Debora C; Figueiredo-Lopes Livia; Alves-Filho Jose C; Semprini Maria C; Gerlach Raquel F; Cunha Fernando Q; Tanus-Santos Jose E
Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
Critical care medicine 2007;35(1):239-45.
-
2007: Tanus-Santos Jose Eduardo; Casella-Filho Antonio
Endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis.
Hypertension 2007;49(1):E1; author reply E2.
-
2007: Fortuna Geisa M; Figueiredo-Lopes Lívia; Dias-Junior Carlos A C; Gerlach Raquel F; Tanus-Santos Jose E
A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism.
International journal of cardiology 2007;114(1):22-7.
-
2007: Sandrim Valeria Cristina; Tanus-Santos Jose Eduardo
Haplotype analysis can provide improved clinical information than single genotype analysis.
Thrombosis research 2007;120(5):779.
-
2006: Dias-Junior Carlos A C; Gladwin Mark T; Tanus-Santos Jose E
Low-dose intravenous nitrite improves hemodynamics in a canine model of acute pulmonary thromboembolism.
Free radical biology & medicine 2006;41(12):1764-70.
-
2006: Sandrim Valéria C; Yugar-Toledo Juan C; Desta Zeruesenay; Flockhart David A; Moreno Heitor; Tanus-Santos Jose E
Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy.
Journal of hypertension 2006;24(12):2393-7.
-
2006: Barbosa Fernando; Sertorio Jonas T C; Gerlach Raquel F; Tanus-Santos Jose E
Clinical evidence for lead-induced inhibition of nitric oxide formation.
Archives of toxicology 2006;80(12):811-6.
-
2006: de Syllos Roger W C; Sandrim Valeria C; Lisboa Hugo R K; Tres Glaucia S; Tanus-Santos Jose E
Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2006;15(4):417-22.
-
2006: Jung Klaus; Gerlach Raquel F; Tanus-Santos Jose E
Preanalytical pitfalls of blood sampling to measure true circulating matrix metalloproteinase 9 and tissue inhibitors of matrix metalloproteinases.
Clinica chimica acta; international journal of clinical chemistry 2006;373(1-2):180-1; author reply 182.
-
2006: Sandrim Valéria C; de Syllos Roger W C; Lisboa Hugo R K; Tres Glaucia S; Tanus-Santos Jose E
Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus.
Atherosclerosis 2006;189(1):241-6.
-
2006: Nagassaki Sabrina; Sertório Jonas T C; Metzger Ingrid F; Bem Andreza F; Rocha João B T; Tanus-Santos Jose E
eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite.
Free radical biology & medicine 2006;41(7):1044-9.
-
2006: Metzger I F; Sertorio J T C; Tanus-Santos J E
Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers.
Acta physiologica (Oxford, England) 2006;188(2):123-7.
-
2006: Barbosa Fernando; Corrêa Rodrigues Maria Heloísa; Buzalaf Maria R; Krug Francisco J; Gerlach Raquel F; Tanus-Santos José Eduardo
Evaluation of the use of salivary lead levels as a surrogate of blood lead or plasma lead levels in lead exposed subjects.
Archives of toxicology 2006;80(10):633-7.
-
2006: Barbosa Fernando; Ramires Irene; Rodrigues Maria Heloísa C; Saint' Pierre Tatiana D; Curtius Adilson J; Buzalaf Marilia R; Gerlach Raquel F; Tanus-Santos José E
Contrasting effects of age on the plasma/whole blood lead ratio in men and women with a history of lead exposure.
Environmental research 2006;102(1):90-5.
-
2006: Gerlach Raquel F; Tanus-Santos Jose E
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis.
Clinical neurology and neurosurgery 2006;108(6):617-8; author reply 618.
-
2006: Ferreira-Melo Silvia Elaine; Yugar-Toledo Juan Carlos; Coelho Otávio Rizzi; De Luca Iara M; Tanus-Santos José Eduardo; Hyslop Stephen; Irigoyen Maria Cláudia; Moreno Heitor
Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
European journal of pharmacology 2006;542(1-3):141-7.
-
2006: Gerlach Raquel F; Tanus-Santos Jose E
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure.
American heart journal 2006;152(1):e9.
-
2006: Montenegro Marcelo F; Barbosa Fernando; Sandrim Valeria C; Gerlach Raquel F; Tanus-Santos Jose E
A polymorphism in the delta-aminolevulinic acid dehydratase gene modifies plasma/whole blood lead ratio.
Archives of toxicology 2006;80(7):394-8.
-
2006: Barbosa Fernando; Gerlach Raquel F; Tanus-Santos Jose E
Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations.
Basic & clinical pharmacology & toxicology 2006;98(6):559-64.
-
2006: Dias-Junior Carlos A; Tanus-Santos Jose E
Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism.
Life sciences 2006;79(5):469-74.
-
2006: Sandrim Valeria Cristina; Coelho Eduardo Barbosa; Nobre Fernando; Arado Gustavo Marin; Lanchote Vera Lucia; Tanus-Santos Jose Eduardo
Susceptible and protective eNOS haplotypes in hypertensive black and white subjects.
Atherosclerosis 2006;186(2):428-32.
-
2006: Montenegro Marcelo F; Barbosa Fernando; Sandrim Valeria C; Gerlach Raquel F; Tanus-Santos Jose E
Ethnicity affects the distribution of delta-aminolevulinic acid dehydratase (ALAD) genetic variants.
Clinica chimica acta; international journal of clinical chemistry 2006;367(1-2):192-5.
-
2006: Tanus-Santos Jose E
L-arginine and pulmonary embolism.
Critical care medicine 2006;34(3):934; author reply 934-5.
-
2006: Demacq Caroline; de Souza Ana P; Machado Alcyone A; Gerlach Raquel F; Tanus-Santos Jose E
Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects.
Clinica chimica acta; international journal of clinical chemistry 2006;365(1-2):183-7.
-
2006: Gerlach Raquel F; Tanus-Santos Jose E
Misuse of serum matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 as a biomarker in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(1):120.
-
2006: Barbosa Fernando; Sandrim Valeria C; Uzuelli Juliana A; Gerlach Raquel F; Tanus-Santos Jose E
eNOS genotype-dependent correlation between whole blood lead and plasma nitric oxide products concentrations.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2006;14(1):58-64.
-
2006: Tanus-Santos Jose E; Gerlach Raquel F
Serum samples should not be used to assess circulating matrix metalloproteinase-9 levels as a prognostic marker of disease.
International journal of cancer. Journal international du cancer 2006;118(3):789; author reply 790.
-
2006: Martinez Marcio L L; Lopes Lívia F; Coelho Eduardo B; Nobre Fernando; Rocha João B T; Gerlach Raquel F; Tanus-Santos Jose E
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension.
Journal of cardiovascular pharmacology 2006;47(1):117-22.
-
2006: Paganelli Maria Ondina; Tanus-Santos José Eduardo; Sabha Maricene; do Prado Joaquim Francisco; Chaud Marco Vinicíus; Martins Luís Cláudio; Moreno Heitor
Hemodynamic effects of bupropion in anesthetized dogs.
European journal of pharmacology 2006;530(1-2):124-7.
-
2006: Paganelli Maria Ondina; Martins Luís Cláudio; Chaud Marco Vinícius; Ferreira-Melo Sílvia Elaine; Sabha Maricene; do Prado Joaquim Francisco; Hyslop Stephen; Tanus-Santos José Eduardo; Moreno Heitor
Hemodynamic effects of a combination of bupropion and nicotine in anesthetized dogs.
Cardiovascular toxicology 2006;6(1):63-8.
-
2005: Gerlach Raquel F; Tanus-Santos Jose E
Circulating matrix metalloproteinase-9 levels as a biomarker of disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8887; author reply 8887-8.
-
2005: Barbosa Fernando; Tanus-Santos José Eduardo; Gerlach Raquel Fernanda; Parsons Patrick J
A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs.
Environmental health perspectives 2005;113(12):1669-74.
-
2005: Souza-Costa Debora C; Zerbini Talita; Palei Ana C; Gerlach Raquel F; Tanus-Santos Jose E
L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9.
Chest 2005;128(5):3705-10.
-
2005: Souza-Silva Allethea R; Dias-Junior Carlos A; Uzuelli Juliana A; Moreno Heitor; Evora Paulo R; Tanus-Santos Jose E
Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension.
European journal of pharmacology 2005;524(1-3):126-31.
-
2005: Palei Ana C T; Zaneti Rafael A G; Fortuna Geisa M; Gerlach Raquel F; Tanus-Santos Jose E
Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism.
Angiology 2005;56(5):611-7.
-
2005: Gerlach Raquel F; Uzuelli Juliana A; Souza-Tarla Caroline D; Tanus-Santos Jose E
Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.
Analytical biochemistry 2005;344(1):147-9.
-
2005: Tanus-Santos Jose E; Gerlach Raquel F
Circulating matrix metalloproteinase-9 levels as a possible marker of aortic stiffness.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(8):e127.
-
2005: Metzger Ingrid F; Souza-Costa Debora C; Marroni Aline S; Nagassaki Sabrina; Desta Zeruesenay; Flockhart David A; Tanus-Santos Jose E
Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men.
Pharmacogenetics and genomics 2005;15(8):565-70.
-
2005: Dias-Junior Carlos A; Souza-Costa Debora C; Zerbini Talita; da Rocha Joao B T; Gerlach Raquel F; Tanus-Santos Jose E
The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension.
Anesthesia and analgesia 2005;101(1):115-20, table of contents.
-
2005: Souza-Tarla Caroline D; Uzuelli Juliana A; Machado Alcyone A; Gerlach Raquel F; Tanus-Santos Jose E
Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.
Clinical biochemistry 2005;38(5):410-4.
-
2005: Marroni Aline S; Metzger Ingrid F; Souza-Costa Debora C; Nagassaki Sabrina; Sandrim Valeria C; Correa Ronan X; Rios-Santos Fabricio; Tanus-Santos Jose E
Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2005;12(3):177-82.
-
2005: Souza-Costa Debora Cristine; Zerbini Talita; Metzger Ingrid Ferreira; Rocha João Batista Teixeira; Gerlach Raquel Fernanda; Tanus-Santos Jose Eduardo
l-Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2005;12(1):9-14.
-
2005: Nagassaki Sabrina; Metzger Ingrid F; Souza-Costa Debora C; Marroni Aline S; Uzuelli Juliana A; Tanus-Santos Jose E
eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population.
Thrombosis research 2005;115(5):375-9.
-
2005: Dias-Junior Carlos A; Vieira Tadeu F; Moreno Heitor; Evora Paulo R; Tanus-Santos Jose E
Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension.
Pulmonary pharmacology & therapeutics 2005;18(3):181-6.
-
2004: Castro Michele M; Rizzi Elen; Rascado Ricardo R; Nagassaki Sabrina; Bendhack Lusiane M; Tanus-Santos Jose E
Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms.
European journal of pharmacology 2004;498(1-3):189-94.
-
2004: Wang Xunde; Tanus-Santos Jose E; Reiter Christopher D; Dejam Andre; Shiva Sruti; Smith Reginald D; Hogg Neil; Gladwin Mark T
Biological activity of nitric oxide in the plasmatic compartment.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(31):11477-82.
-
2004: Yugar-Toledo Juan Carlos; Tanus-Santos Jose Eduardo; Sabha Maricene; Sousa Márcio Gonçalves; Cittadino Máira; Tácito Lúcia Helena Buonalumi; Moreno Heitor
Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction.
Chest 2004;125(3):823-30.
-
2004: Tanus-Santos José Eduardo
Pharmacologic therapy of pulmonary vasoconstriction in acute pulmonary embolism.
Anesthesia and analgesia 2004;98(1):273.
-
2003: Arefayene Million; Skaar Todd C; Zhao Xiaojiong; Rae James M; Tanus-Santos Jose E; Brinkmann Ulrich; Brehm Ilka; Salat Ulrike; Nguyen Anne; Desta Zeruesenay; Flockhart David A
Sequence diversity and functional characterization of the 5'-regulatory region of human CYP2C19.
Pharmacogenetics 2003;13(4):199-206.
-
2003: Cittadino Máira; Gonçalves de Sousa Márcio; Ugar-Toledo Juan Carlos; Rocha João Carlos; Tanus-Santos José Eduardo; Moreno Heitor
Biochemical endothelial markers and cardiovascular remodeling in refractory arterial hypertension.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2003;25(1):25-33.
-
2003: Desai M; Tanus-Santos J E; Li L; Gorski J C; Arefayene M; Liu Y; Desta Z; Flockhart D A
Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6.
The pharmacogenomics journal 2003;3(2):105-13.
-
2002: Reiter Christopher D; Wang Xunde; Tanus-Santos Jose E; Hogg Neil; Cannon Richard O; Schechter Alan N; Gladwin Mark T
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.
Nature medicine 2002;8(12):1383-9.
-
2002: Sampaio Rita C; Tanus-Santos Jose E; Melo Silvia E S F C; Hyslop Stephen; Franchini Kleber G; Luca Iara M; Moreno Heitor
Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats.
Chest 2002;122(4):1412-20.
-
2002: Tanus-Santos Jose E; Desai Mehul; Deak Leslie R; Pezzullo John C; Abernethy Darrell R; Flockhart David A; Freedman Jane E
Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol.
Pharmacogenetics 2002;12(5):407-13.
-
2002: Flockhart David A; Tanus-Santos Jose E
Implications of cytochrome P450 interactions when prescribing medication for hypertension.
Archives of internal medicine 2002;162(4):405-12.
-
2002: Tanus-Santos Jose E; Theodorakis Michael J
Is there a place for inhaled nitric oxide in the therapy of acute pulmonary embolism?
American journal of respiratory medicine : drugs, devices, and other interventions 2002;1(3):167-76.
-
2001: Tanus-Santos J E; Desai M; Flockhart D A
Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants.
Pharmacogenetics 2001;11(8):719-25.
-
2001: Tanus-Santos J E; Toledo J C; Cittadino M; Sabha M; Rocha J C; Moreno H
Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers.
American journal of hypertension 2001;14(7 Pt 1):610-4.
-
2001: Coelho-Filho O R; De Luca I M; Tanus-Santos J E; Cittadino M; Sampaio R C; Coelho O R; Hyslop S; Moreno Júnior H
Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats.
International journal of cardiology 2001;79(2-3):215-21.
-
2001: Paganelli M O; Tanus-Santos J E; Toledo J C; do Prado J F; Calegari V; Moreno H
Acute administration of nicotine impairs the hypotensive responses to bradykinin in rats.
European journal of pharmacology 2001;413(2-3):241-6.
-
2000: Tanus-Santos J E; Gordo W M; Cittadino M; Moreno H
Plasma cGMP levels in air embolism-induced acute lung injury.
Journal of critical care 2000;15(4):137-41.
-
2000: Sabha M; Tanus-Santos J E; Toledo J C; Cittadino M; Rocha J C; Moreno H
Transdermal nicotine mimics the smoking-induced endothelial dysfunction.
Clinical pharmacology and therapeutics 2000;68(2):167-74.
-
2000: Tanus-Santos J E; Gordo W M; Udelsmann A; Cittadino M H; Moreno H
Nonselective endothelin-receptor antagonism attenuates hemodynamic changes after massive pulmonary air embolism in dogs.
Chest 2000;118(1):175-9.
-
2000: Tanus-Santos J E; Gordo W M; Francisco-DoPrado J; Sampaio R C; Moreno H
Endothelin-1 attenuates bradykinin-induced hypotension in rats.
European journal of pharmacology 2000;397(2-3):367-71.
-
2000: Tanus-Santos J E; Sampaio R C; Hyslop S; Franchini K G; Moreno H
Endothelin ET(A) receptor antagonism attenuates the pressor effects of nicotine in rats.
European journal of pharmacology 2000;396(1):33-7.
-
2000: Tanus-Santos J E; Gordo W M; Udelsmann A; Moreno H
The hemodynamic effects of endothelin receptor antagonism during a venous air infusion in dogs.
Anesthesia and analgesia 2000;90(1):102-6.
-
1999: Tanus-Santos J E; Moreno H
Capnography and the diagnosis of gas embolism.
Anaesthesia and intensive care 1999;27(6):667.
-
1999: Faro R; Tanus-Santos J E; Zappellini A; Antunes E; De Nucci G
The role of heart rate in the modulation of the decreased cardiac output induced by acute nitric oxide synthesis inhibition in anaesthetized dogs.
Journal of autonomic pharmacology 1999;19(5):257-62.
-
1999: Tanus-Santos J E; Moreno H; Moreno R A; Martins M L; Pereira R; de Nucci G
Inhaled nitric oxide improves hemodynamics during a venous air infusion (VAI) in dogs.
Intensive care medicine 1999;25(9):983-9.
-
1999: Tanus-Santos J E; Moreno H
Inhaled nitric oxide as a coadjuvant therapy after massive pulmonary embolism.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 1999;46(9):906.
-
1999: Moreno H; Tanus-Santos J E
Nitric oxide inhalation during massive pulmonary embolism.
Anesthesia and analgesia 1999;88(5):1188.
-
1999: Tanus-Santos J E; Moreno H; Zappellini A; de Nucci G
Small-dose inhaled nitric oxide attenuates hemodynamic changes after pulmonary air embolism in dogs.
Anesthesia and analgesia 1999;88(5):1025-9.
-
1999: Tanus-Santos J E; Moreno H
The use of inhaled nitric oxide during gas embolism.
Chest 1999;115(4):1220-1.
-
1999: Tanus-Santos J E; Moreno H
Inhaled nitric oxide and amniotic fluid embolism.
Anesthesia and analgesia 1999;88(3):691.
Sign-in to see more